IMV Executive Assistant
tel. (612) 624-1926
fax. (612) 625-1108
18-242 Moos Tower
515 Delaware St. SE
Minneapolis, MN 55455
Phone: (612) 624-5172
HTLV-1 particle morphology
My research seeks to genetically engineer HTLV-1/HIV-1 Gag chimeras to test the hypothesis that the CA domain plays a significant role in determining HTLV-1 particle size and Gag content. The particular chimeras that I will be creating will have the MA, CA or NC domain swapped from the original wild-type with the MA,CA or NC domain from the other virus (i.e. an HTLV-1 construct will be made to contain the MA,CA or NC domain of HIV-1 and an HIV-1 construct will be made to contain the MA, CA or NC domain of HTLV-1). These constructs will be used in a broader study of HTLV-1 and its morphology, particle size, Gag stoichiometry, Gag-Gag interactions, and Gag-membrane interactions.
'Wisc-e-sota', a Joint UMN-UW Virology Training Grant Symposium was first held on Friday, Sepbember 20th, 2013 at the Uniiversity of Wisconsin-La Crosse, Cartwright Center. This was the inaugural collaborative symposium of the NIH T32-supported virology training programs at the University of Wisconsin-Madison and the University of Minnesota-Twin Cities. Talks and poster sessions were presented by students, postdocs and faculty. The second UMN-UW Virology Training Grant Symposium will be held in the Fall 2014. Details to follow.
The 2014 IMV Symposium will be held on May 12, 2014 and Mark Denison (Vanderbilt) and Bert Semler (UC-Irvine) will be the Keynote Speakers. Click on the link below to register and submit abstracts.
Read about bacteriophage phi 29 and why it matters.
Explore nearly a century's worth of discovery in the field of virology at the University of Minnesota.
"This Week in Virology" from professor Vincent Racaniello.